RESULTS:
Overall, muscle flaps predominated (75%) over fasciocutaneous (25%) and major perioperative complications occurred in 111 flaps (27%): 71 takebacks (17%); 45 partial losses (11%); 37 complete losses (9%). Time to coverage was <10 days in 33%, 11-90 days in 35%, and >90 days in 32% of patients. Decreasing arterial runoff directly correlated with increased complications (p=0.048): compared to 3-vessel legs, 2-vessel had increased flap failures (RR=2.08, p=0.041), and 1-vessel had even higher failure risk (RR=3.67, p=0.001). There were 224 patients with 3-vessel runoff: 96 had end-to-end anastomosis and 128 with end-to-side anastomosis. An increased number of overall complications was noted in the end-to-side group compared to the end-to-end group (34% vs. 19%, p<0.01), but there was no difference in takebacks, flap loss or flap salvage rates. There were 68 patients identified with 2-vessel runoff in the leg: 23 with end-to-end into an injured vessel, 3 end-to-end into an uninjured vessel, and 42 endto-side into an uninjured vessel. No difference between the groups was noted in terms of takebacks, flap loss or flap salvage rates, although vein grafts were required more often in the end-to-side groups (p <0.01). There were 39 patients identified with 1-vessel runoff in the leg: 22 had end-toend anastomosis into an injured vessel and 17 with end-toside anastomosis into an uninjured vessel. No difference between the groups was noted in terms of takebacks, flap loss or flap salvage rates, with a non-statistically significant trend toward more complications in the end-to-end group.
CONCLUSION:
Lower extremity trauma reconstruction remains challenging and should be tailored to each individual patient. While the number of patent arteries does impact outcomes in lower extremity reconstruction, within each group, no superior microvascular anastomosis technique was identified: end-to-end vs. end-to-side and injured vs. 
QS11 Stem Cell Therapy Enriched Fat Graft Reconstruction of Craniofacial Deficits
Debra A. Bourne, MD 1 PURPOSE: Craniofacial deformities have serious psychosocial sequelae and can profoundly affect quality of life. Fat grafting is an effective treatment for craniofacial deformities. Stromal vascular fraction (SVF) is a concentrated form of adipose derived stem cells (ASC) that can be isolated from fat through collagenase based procedures. The aim of this clinical trial is to assess the impact of SVF enrichment on craniofacial fat grafting.
METHODS:
This IRB-approved prospective cohort study was funded by the Department of Defense. Twelve subjects with at least two regions of craniofacial volume deficit were enrolled and underwent fat grafting with SVF-enriched or standard fat grafting to each area. All patients had bilateral malar regions injected with SVF-enriched graft on one side and control standard fat grafting to the contralateral side. Outcome assessments included: 1) demographic information; 2) volume retention determined by CT scans; 3) SVF cell populations by flow cytometry; 4) SVF cell viability; and, 5) complications. Follow-up was 9 months.
RESULTS:
All patients had subjective improvement in appearance. There were no serious adverse events. There was no significant difference in volume retention between the SVF-enriched and control regions overall (50.3% vs 57.3%, p=0.269) or comparing malar regions (51.4% vs 56.7%, p=0.494). Patient age, smoking status, obesity, and diagnosis of diabetes did not impact volume retention. Cell viability was 77.4 ± 7.3%. Cellular subpopulations were 60.1 ± 11.2% ASCs, 12.2 ± 7.0% endothelial cells, and 9.2 ± 4.4% pericytes. There was no significant correlation between cell viability or cellular subpopulations and volume retention.
CONCLUSIONS:
Autologous fat transfer for the reconstruction of craniofacial defects is effective and safe. SVF enrichment does not significantly impact volume retention. (2), with the understanding being that tissue oximetry can alert the surgeon to flap compromise hours before the skin paddle shows clinical signs of it. The same studies however, take note of the shortfalls of tissue oximetry, namely, obtaining reproducible and reliable readings, and then interpretation of results prompting re-exploration in the OR (4). We present our in-vivo simulation of venous congestion in tissue oximetry in hopes to better delineate early signs of flap compromise and tissue physiology.
METHODS:
Seventeen random subjects' baseline blood pressure and tissue oximetry readings on the upper extremity were obtained. The subjects' diastolic pressure was used to determine venous occlusion pressure, and a BP cuff was applied to that pressure on the arm(5). Tissue oximetry was recorded for a duration of 10-15 minutes. A linear mixed model was used to analyze the data.
RESULTS:
Tissue oximetry (StO 2 ) levels fell in a predictable and reproducible manner across all subjects. The correlation between StO 2 and time was analyzed with a linear mixed model, which suggested a significant decrease of StO 2 with time (P<.0001). Specifically, the StO 2 decreased 1.38 percent per minute on average (95%CI -1.51, -1.26) after the cuff was applied. Subjects with a smoking history and breast cancer history failed to demonstrate a significant difference among the group.
